Try our beta test site
576 studies found for:    PAH
Show Display Options
Rank Status Study
21 Completed Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA)
Condition: Pulmonary Arterial Hypertension
Intervention:
22 Completed Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)
Condition: Hypertension, Pulmonary
Intervention: Drug: Assigned pulmonary hypertension medication
23 Active, not recruiting Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years
Condition: PAH
Intervention: Drug: oral treprostinil
24 Recruiting National Cohort Study of Idiopathic and Heritable Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention:
25 Completed A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Beraprost sodium modified release
26 Enrolling by invitation Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Inhaled Nitric Oxide
27 Active, not recruiting Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAH
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Macitentan
28 Completed Responsiveness of Exercise Tests in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Sildenafil;   Drug: Sugar Pill
29 Completed Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Sorafenib
30 Completed Carvedilol PAH A Pilot Study of Efficacy and Safety
Conditions: Pulmonary Hypertension;   Cardiac MRI <40
Intervention: Drug: Carvedilol
31 Not yet recruiting Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients
Condition: Pulmonary Arterial Hypertension (PAH)
Interventions: Drug: QCC374;   Drug: Placebo Matching
32 Recruiting Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: iNO 15 mcg/kg IBW/hr;   Drug: iNO 75 mcg/kg IBW/hr;   Drug: Placebo Dose setting of 15 mcg/kg IBW/hr;   Drug: Placebo Dose setting of 75 mcg/kg IBW/hr
33 Not yet recruiting A Study to Find Out Whether the Medicine Macitentan Works in Children With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Macitentan;   Other: Standard-of-care
34 Active, not recruiting Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Macitentan
35 Completed Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: udenafil;   Drug: placebo
36 Completed Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAH
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Udenafil
37 Completed
Has Results
Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Sitaxentan sodium
38 Completed Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Beraprost Sodium Modified Release
39 Unknown  The Expression and Significance of MiRNA
Condition: Pulmonary Arterial Hypertension
Intervention:
40 Terminated A Pulmonary Arterial Hypertension Study With Macitentan to Validate the PAH-SYMPACT™ in France, Italy and Spain
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Macitentan

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.